SLC7A11 and neoplasm: In this latter scenario, the decreased SLC7A11 levels apparently cannot explain tumor phenotypes in the corresponding cancers; instead, it is proposed that this decreased SLC7A11 expression creates an Achilles heel for therapeutic targeting in tumors with low expression of SLC7A11, as such tumors presumably should be more vulnerable to oxidative stress.